Compare MESO & KALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MESO | KALU |
|---|---|---|
| Founded | 2004 | 1946 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | N/A | 1991 |
| Metric | MESO | KALU |
|---|---|---|
| Price | $18.66 | $123.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $24.00 | ★ $99.67 |
| AVG Volume (30 Days) | ★ 214.0K | 162.3K |
| Earning Date | 02-25-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | N/A | ★ 58.01 |
| EPS | N/A | ★ 5.17 |
| Revenue | $17,198,000.00 | ★ $3,209,400,000.00 |
| Revenue This Year | $576.59 | $12.83 |
| Revenue Next Year | $41.15 | $12.98 |
| P/E Ratio | ★ N/A | $24.63 |
| Revenue Growth | ★ 191.39 | 7.69 |
| 52 Week Low | $9.61 | $46.81 |
| 52 Week High | $21.50 | $135.48 |
| Indicator | MESO | KALU |
|---|---|---|
| Relative Strength Index (RSI) | 52.89 | 54.37 |
| Support Level | $16.67 | $125.14 |
| Resistance Level | $19.00 | $135.48 |
| Average True Range (ATR) | 0.67 | 4.26 |
| MACD | -0.07 | -0.75 |
| Stochastic Oscillator | 40.79 | 27.81 |
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.